Twist Bioscience Corp. (TWST)
188.67
+0.62
(+0.33%)
USD |
NASDAQ |
Oct 02, 16:00
189.79
+1.12
(+0.59%)
Pre-Market: 20:00
Twist Bioscience Market Cap : 11.82B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.82B |
| October 01, 2026 | 11.79B |
| September 30, 2026 | 12.11B |
| September 29, 2026 | 11.67B |
| September 28, 2026 | 11.26B |
| September 25, 2026 | 11.46B |
| September 24, 2026 | 11.53B |
| September 23, 2026 | 9.934B |
| September 22, 2026 | 10.32B |
| September 21, 2026 | 10.39B |
| September 18, 2026 | 10.47B |
| September 17, 2026 | 9.750B |
| September 16, 2026 | 8.967B |
| September 15, 2026 | 8.655B |
| September 14, 2026 | 8.445B |
| September 11, 2026 | 7.973B |
| September 10, 2026 | 7.950B |
| September 09, 2026 | 7.867B |
| September 08, 2026 | 8.026B |
| September 04, 2026 | 7.817B |
| September 03, 2026 | 8.067B |
| September 02, 2026 | 8.210B |
| September 01, 2026 | 8.277B |
| August 31, 2026 | 8.712B |
| August 28, 2026 | 8.861B |
| Date | Value |
|---|---|
| August 27, 2026 | 9.595B |
| August 26, 2026 | 9.405B |
| August 25, 2026 | 9.490B |
| August 24, 2026 | 8.824B |
| August 21, 2026 | 9.125B |
| August 20, 2026 | 8.544B |
| August 19, 2026 | 8.924B |
| August 18, 2026 | 7.276B |
| August 17, 2026 | 7.797B |
| August 14, 2026 | 7.431B |
| August 13, 2026 | 7.852B |
| August 12, 2026 | 7.847B |
| August 11, 2026 | 7.716B |
| August 10, 2026 | 7.827B |
| August 07, 2026 | 7.250B |
| August 06, 2026 | 6.836B |
| August 05, 2026 | 7.208B |
| August 04, 2026 | 6.233B |
| August 03, 2026 | 6.334B |
| July 31, 2026 | 5.738B |
| July 30, 2026 | 5.724B |
| July 29, 2026 | 5.312B |
| July 28, 2026 | 5.504B |
| July 27, 2026 | 5.379B |
| July 24, 2026 | 5.611B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.530B |
| Intellia Therapeutics, Inc. | 1.717B |
| Prime Medicine, Inc. | 538.60M |
| Absci Corp. | 1.899B |
| 10X Genomics, Inc. | 12.18B |
Market Cap Related Metrics
| PS Ratio | 26.83 |
| PEG Ratio | -1.596 |
| Price to Book Value | 26.53 |
| Price | 188.67 |
| Earnings Yield | -1.18% |
| PEGY Ratio | -1.596 |